The Cytel Blog: Perspectives on Enquiry & Evidence

An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread..

Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars..

Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,..

  In this blog we turn to some reading matter, and interview Gautier Paux and Alex Dmitrienko about the recent book..

 In this blog we are excited to unveil a new project which we have been hard at work on over the last few months.  2017..

Single ascending dose (SAD) and multiple ascending dose (MAD) studies are typically the first in human studies.  They..

As a group, Cytel had over 40 successful regulatory interactions last year, many of which supported approvals for..

   Francois Beckers, Global Head of Biostatistics & Epidemiology at Merck KGaA joined us at the East User Group Meeting..

On March 16th and 17th the 5th East User Group Meeting took place in London.  This very successful 2 days saw a variety..